PHARMING GROUP N.V. |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.897 EUR | -1.21% |
|
-6.61% | -13.00% |
| Apr. 22 | Pharming Group to Buy Back EUR123 Million of Bonds due 2025 | MT |
| Apr. 18 | Pharming Group to Issue EUR100 Million Convertible Bonds, Repurchase EUR125 Million Bonds | MT |
Chart calendar Pharming Group N.V.
d783581dba59734d7d029580.t_KFAdd4NWMPk0Pc_iHIeWnbz9CAsq9jz2Nw2YnqQA4.5KLCbY8cAAJJ_nKRpm6mDgu_pOPw_OJWvSwYusG7C3vVmvVbghIDGmTmLA~e58972680b3864ffb07a6ef495ceaab1
Upcoming events on Pharming Group N.V.
Past events on Pharming Group N.V.
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-04-08 08:45 am | Needham Healthcare Conference |
| 2024-03-14 08:30 am | Q4 2023 Earnings Call |
| 2024-03-14 02:00 am | Q4 2023 Earnings Release |
| 2024-02-27 | UBS European Healthcare Conference |
| 2024-02-27 | Morgan Stanley European MedTech and Life Sciences Conference |
| 2024-02-13 11:20 am | Oppenheimer Healthcare Life Sciences Conference |
| 2023-11-14 08:35 am | Stifel Healthcare Conference |
| 2023-11-14 03:30 am | Jefferies London Healthcare Conference |
| 2023-11-12 03:15 pm | American College of Allergy, Asthma & Immunology Scientific Meeting - Poster #M150 |
| 2023-11-11 03:35 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster #P166 |
| 2023-11-11 03:20 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster #P165 |
| 2023-11-10 06:00 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster #M234 |
| 2023-11-10 09:15 am | International Primary Immunodeficiencies Congress - Poster #152 |
| 2023-11-09 04:00 am | International Primary Immunodeficiencies Congress - Poster #214 |
| 2023-11-09 02:00 am | International Primary Immunodeficiencies Congress - Poster #204 |
| 2023-10-26 07:30 am | Q3 2023 Earnings Call |
| 2023-10-26 01:00 am | Q3 2023 Earnings Release |
| 2023-09-28 10:20 am | Cantor Global Healthcare Conference |
| 2023-09-25 08:00 am | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 169 170 -0.71% | 186 184 1.18% | 181 178 1.35% | 195 194 0.35% | 224 226 -0.84% | 262 |
|
EBITDA Million EUR | Released Forecast Spread | 66,1 61,7 7.16% | 75,7 74,8 1.25% | 51,4 43,5 17.99% | 29,8 30,1 -0.88% | 9,63 2,48 288.33% | 10,1 |
|
EBIT Million EUR | Released Forecast Spread | 60,9 57,0 6.91% | 67,4 69,4 -2.89% | 33,5 25,7 30.56% | 17,3 22,6 -23.39% | -4,92 -7,59 35.12% | -7,15 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 46,7 42,3 10.24% | 39,3 44,7 -12.05% | 21,0 25,2 -16.8% | 14,2 43,0 -66.93% | -11,0 -5,14 -113.56% | 3,45 |
|
Net income Million EUR | Released Forecast Spread | 36,2 30,3 19.58% | 32,7 31,5 3.61% | 14,5 17,1 -15.09% | 13,0 33,7 -61.53% | -9,25 -3,75 -146.33% | 1,33 |
|
EPS EUR | Released Forecast Spread | 0,05 0,05 13.68% | 0,05 0,05 -5.44% | 0,02 0,05 -56.17% | 0,00 0,00 - | -0,01 -0,01 -53.44% | 0,00 |
| Announcement Date | 05/03/20 | 04/03/21 | 17/03/22 | 16/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 88,6 101 -12.28% | 78,7 84,4 -6.7% | 62,4 50,8 22.95% | 44,2 44,3 -0.18% | 49,0 50,8 -3.46% | 94,6 95,6 -1.11% | 53,9 53,6 0.46% | 51,8 54,0 -3.99% | 38,8 44,7 -13.32% | 50,2 48,4 3.79% | 89,1 88,0 1.24% | 63,0 56,3 11.85% | 74,2 | 64,3 | 66,1 | 66,1 | 66,2 | |
|
EBIT Million EUR | Released Forecast Spread | 7,61 3,97 91.58% | 17,4 5,93 193.71% | 7,71 1,51 411.74% | -9,66 0,81 -1289.41% | -12,4 -0,19 -6591.93% | 4,85 -0,80 709.22% | 1,79 -1,54 216.54% | 1,01 -3,76 126.76% | 1,88 | -1,99 | 54,9 | -70,7 | ||||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 25,9 26,3 -1.54% | 16,9 22,5 -24.91% | 3,58 3,81 -5.86% | 4,02 -3,09 229.77% | 19,1 6,63 188.3% | 23,3 10,4 124.23% | 9,22 5,14 79.32% | -17,2 6,36 -369.94% | -15,2 -3,03 -400.66% | 3,10 -7,03 144.05% | -12,2 -24,5 50.31% | 3,12 -8,16 138.19% | -1,83 5,24 -134.86% | 6,85 | 5,37 | 22,0 | 29,8 | -35,7 |
|
Net income Million EUR | Released Forecast Spread | 18,1 17,8 1.93% | 12,1 16,4 -25.92% | 3,21 2,75 16.91% | 3,28 -4,50 172.97% | 15,3 5,45 181.39% | 18,8 8,84 112.46% | 9,04 2,42 274.25% | -13,9 3,86 -459.83% | -11,1 -3,85 -189.1% | 1,21 -10,4 111.6% | -9,96 -26,4 62.25% | 3,31 -8,68 138.07% | -2,47 4,15 -159.52% | 6,03 | 4,55 | 18,7 | 28,9 | -36,5 |
|
EPS EUR | Released Forecast Spread | 0,03 0,02 4.17% | 0,02 0,02 -33.13% | 0,01 0,01 158.2% | |||||||||||||||
| Announcement Date | 30/07/20 | 05/08/21 | 17/03/22 | 12/05/22 | 04/08/22 | 04/08/22 | 27/10/22 | 16/03/23 | 11/05/23 | 03/08/23 | 03/08/23 | 26/10/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for Pharming Group N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHARM Stock
- Calendar Pharming Group N.V.
